Tag Invest Wisely

Amber Enterprises Ltd
Amber Enterprises: Market Performance, Growth Insights and Stock Decline in ‘A’ Group

Business and Industry Overview: 

Amber Enterprises India Limited is a leading company that makes air conditioners and their parts. It has been in this business for over 30 years. The company provides full solutions for heating, ventilation, and air conditioning (HVAC). It works with big brands in India and other countries. It makes important parts like heat exchangers, copper tubing, and plastic parts. These parts help improve the quality and performance of air conditioners. 

The company has different divisions. The consumer durables division focuses on making air conditioners. The electronics division makes printed circuit boards (PCBs). These are used in cars, home appliances, and industrial machines. The company also makes special PCBs for airplanes and defense equipment. The railway and defense division makes parts for trains. It also provides cooling systems for telecom, buses, and defense projects. 

Amber Enterprises has 30 factories in India. It has more than 18,000 employees. Over 250 engineers work in research and development (R&D). The company invests in new technology and better products. It focuses on making high-quality products that are also good for the environment. 

As of March 2025, the company has a market value of ₹24,286 crore. Its stock price is ₹7,180. It is listed on the stock market with codes BSE 540902 and NSE AMBER. The company is growing steadily and making profits. 

Amber Enterprises has strong leadership. Kartar Singh is the Chairman. Daljit Singh is the Managing Director. Sudhir Goyal is the Chief Financial Officer (CFO). Konica Yadav is the Company Secretary. The company keeps improving its products. It is known for its focus on innovation, quality, and sustainability. 

The HVAC (Heating, Ventilation, and Air Conditioning) industry in India is growing quickly. Many factors are driving this growth. More people are moving to cities. This increases the need for air conditioners in homes, offices, shopping malls, hospitals, and other buildings. Rising incomes allow people to buy better cooling systems. The climate is changing, making air conditioning necessary in many places. Summers are getting hotter, increasing demand for cooling. As real estate grows, more buildings need HVAC systems for comfort. 

The Indian government is supporting this industry in many ways. Programs like ‘Make in India’ and ‘Atmanirbhar Bharat’ encourage companies to manufacture HVAC products within the country. The Production Linked Incentive (PLI) scheme provides financial support to increase production. The government has also set energy efficiency goals. These aim to reduce electricity use and help India become carbon neutral by 2070. These policies encourage the use of eco-friendly and energy-efficient HVAC systems. 

Experts predict that the Indian HVAC market will reach $30 billion by 2030. It is expected to grow at an annual rate of 15.8%. People are becoming more aware of indoor air quality. They also understand the benefits of energy-efficient cooling systems. This awareness is driving demand for advanced HVAC solutions. New smart technology is improving HVAC systems. IoT-based air conditioners, smart thermostats, and automated climate control systems are making cooling more efficient and easier to use. 

There are many opportunities in this sector. The middle-class population is growing. More people are buying air conditioners. Smaller cities and towns, known as Tier II and Tier III cities, are developing rapidly. This creates a huge market for HVAC products. New technology, like variable refrigerant flow (VRF) systems, helps save energy. Green building projects are also increasing. Certifications like Leadership in Energy and Environmental Design (LEED) and Green Rating for Integrated Habitat Assessment (GRIHA) encourage the use of energy-saving HVAC systems. There is also a high demand for maintenance and repair services. Companies providing these services have great business opportunities. 

However, the industry faces some challenges. Air conditioning systems are expensive. Many people in India cannot afford them. There is also a shortage of skilled technicians. Installing and maintaining HVAC systems requires trained professionals. Meeting government energy efficiency standards is difficult for some companies. Many consumers do not know about the benefits of energy-efficient air conditioners. This slows down the adoption of new technology. 

Despite these challenges, the HVAC industry in India has a bright future. More people are buying air conditioners. Companies are developing better technology. The government is providing strong support. Businesses that focus on energy-efficient, smart, and eco-friendly HVAC solutions have great potential. The industry will continue to grow as technology improves. More people will understand the importance of good indoor air quality and energy savings. This will help the HVAC sector expand further in the coming years. 

Amber Enterprises Ltd. is a big company in India. It makes air conditioners and their important parts like heat exchangers, copper tubes, and plastic parts. Many famous brands trust Amber to make their products. The company has 30 factories across India. These factories help in making products fast and delivering them on time. 

Amber has 250+ engineers who work on new ideas. They try to make air conditioners better and save more energy. The company also makes printed circuit boards (PCBs). These are used in TVs, cars, airplanes, and other machines. Amber also provides cooling systems for trains, buses, and the army. This helps the company grow in different industries. 

The Indian government supports companies that manufacture in India. Programs like ‘Make in India’ and the PLI scheme help Amber make more products at lower costs. The government also wants to reduce pollution and save energy by 2070. Because of this, energy-saving air conditioners are becoming more popular. Amber is working on products that use less electricity and are better for the environment. 

Amber faces some challenges. Many companies make air conditioners, so there is a lot of competition. The prices of materials like copper and aluminum keep changing. This makes it hard to control costs. There are not enough trained workers to install and repair air conditioners. The government also has strict rules that companies must follow. 

Even with these challenges, Amber is growing fast. More people in India are buying air conditioners for homes, offices, and malls. Amber is making smart and energy-saving air conditioners to meet this demand. With strong factories, expert engineers, and government help, Amber will keep growing and remain a leader in the air conditioning industry. 

Latest Stock News: 

Amber Enterprises is a leading company in India. It makes air conditioners and important electronic parts. Many big brands buy these products from Amber. The company is growing fast because more people are buying air conditioners. Electronics demand is also increasing. In the last three months, Amber’s sales grew by 65% compared to last year. This growth came from strong demand for cooling and electronic products. More homes, offices, and factories need air conditioning. The electronics division is also expanding fast. Amber supplies parts for industries like automobiles, consumer electronics, and industrial machines. To grow even more, Amber is making big investments. It is spending INR 6.5 billion on Ascent Circuits, a company that makes electronic parts. This will help Amber expand its electronics business. Amber is also working with a Korean company to make more products in India. This is part of the Production Linked Incentive (PLI) scheme. The Indian government supports local manufacturing through programs like ‘Make in India’ and ‘Atmanirbhar Bharat’. This helps companies like Amber produce more and rely less on imports. 

Amber’s financial future looks strong. Experts say its sales will grow by 26% per year from FY24 to FY27. Its profits will also increase quickly. The company’s earnings before costs (EBITDA) will grow by 33% per year. Its net profit (PAT) will rise by 62% per year. This means Amber is becoming more successful and making more money. 

Amber’s stock has performed better than the Sensex. It has given good returns over both short-term and long-term periods. However, on March 21, 2025, the stock price fell after a four-day gain streak. Despite this, Amber remains a strong company with good future growth potential. 

With more demand for air conditioners and electronics, Amber is in a great position. It is increasing production and bringing in new technology. Government support is helping the company grow. With strong sales, big investments, and a focus on new opportunities, Amber is expected to expand even more in the coming years. 

Potentials: 

Amber Enterprises is growing fast and has big plans for the future. It is building two new factories to make more air conditioners and electronic parts. The company is also expanding into electronics by making its own printed circuit boards (PCBs) through a new partnership with Korea Circuits. Amber is entering the washing machine business by working with Resojet to make fully automatic washing machines. It is also making parts for trains and has partnered with Titagarh Rail Systems and Yujin Machinery to supply train doors and other components. Amber wants to sell more products in other countries and has set up a sales team in the U.S. to find new customers. The Indian government is helping local manufacturers through the Production Linked Incentive (PLI) scheme, which benefits Amber. With these plans, the company is set to grow in different industries and expand its business. 

Analyst Insights: 

  • Market capitalisation: ₹ 23,648 Cr.. 
  • Current Price: ₹ 6,991 
  • 52-Week High/Low: ₹ 8,177 / 3,310 
  • Stock P/E: 106 
  • Dividend Yield: 0.00 % 
  • Return on Capital Employed (ROCE):10.2 % 
  • Return on Equity: 6.74 % 

Amber Enterprises holds a 29% market share in the room air conditioner (RAC) industry and has shown 28.2% median sales growth over the last decade, with a 30% CAGR in revenue over the last three years, reaching ₹9,025 Cr in TTM revenue. However, the stock is highly overvalued, trading at a P/E of 106.4x, significantly above the sector median (~44x), and at 11.2x its book value, despite low ROE (6.74%) and ROCE (10.2%). The company’s debt has also increased from ₹1,455 Cr in 2023 to ₹1,539 Cr in 2024, and it has no dividend payout. While institutional investors remain confident, and industry tailwinds support growth, the low profit margins (~2%) and high valuation warrant caution, making it a hold for existing investors while new investors should wait for a correction. 

IREDA Ltd
IREDA Shares Surge 3.94% as Borrowing Limit Rises by ₹5,000 Crore for FY25

Business and Industry Overview: 

Indian Renewable Energy Limited (IREL) and the Indian Renewable Energy Development Agency (IREDA) are both working towards clean energy in India. IREL is a private company that focuses on solar energy projects and explores new investments in power generation. It helps set up rooftop solar plants and looks for ways to grow in the renewable sector. IREDA, on the other hand, is a government-backed financial institution. It provides loans and financial help to projects related to solar, wind, hydro, and energy efficiency. IREDA was set up in 1987 and works under the Ministry of New and Renewable Energy (MNRE). It ensures that businesses and individuals get funding to invest in green energy. The company also follows strict rules for ethical business, data security, and quality management. Both organizations aim to make renewable energy more affordable and accessible. They want India to use cleaner power sources, reduce pollution, and move towards a sustainable future. 

India’s renewable energy industry is growing very fast. The government wants to produce 500 GW of electricity from clean energy sources like solar, wind, and hydro by 2030. In 2023, India added 13.5 GW of renewable energy capacity. This was done with an investment of Rs. 74,000 crore (US$ 8.90 billion). India has a bigger plan to invest Rs. 9.22 lakh crore (US$ 109.50 billion) to build more energy infrastructure and meet the demand, which is expected to be 458 GW by 2032. 

The government is focusing a lot on solar energy. In the 2024-2025 budget, they increased the money for building solar power grids to Rs. 8,500 crore (US$ 1.02 billion), which is double what they spent the year before. The government is also supporting clean energy like green hydrogen and electric vehicles (EVs). Indian companies plan to invest Rs. 67,42,400 crore (US$ 800 billion) in these areas. 

The government is also helping farmers through the PM-KUSUM scheme, which gives money to farmers to set up solar pumps and solar power plants. This helps them with their farming and water needs. In Rajasthan, the government signed a deal with NTPC Green Energy to set up 28,500 MW of renewable energy projects. 

As of 2023, India is ranked 4th in the world for wind power, solar power, and overall renewable energy capacity. India is also a top leader in cutting down carbon emissions. It is one of the top three countries in the world for reporting and reducing carbon emissions. With more investments, clear government plans, and a focus on clean energy, India is becoming a leader in renewable energy and is moving towards a cleaner and more sustainable future. 

IREDA is a strong player in India’s renewable energy market. It gets a lot of support from the government, which helps it provide loans and funding for clean energy projects. IREDA has been around since 1987 and is known for helping build projects in solar, wind, and energy efficiency. It works closely with the government’s plans to increase clean energy in the country. IREDA also has a good reputation for being reliable and transparent in its work. As the demand for renewable energy grows, IREDA is in a good position to keep helping develop new energy sources, even though there are new private companies entering the market. 

Latest Stock News: 

Shares of Indian Renewable Energy Development Agency Ltd (IREDA) have dropped 53% from their highest value of Rs 310 in July 2024. The stock is now in the oversold zone, with an RSI (Relative Strength Index) of 26.6, meaning the stock could be undervalued. When the RSI is below 30, it shows the stock is oversold, and when it’s above 70, it’s overbought. On March 20, 2024, the stock went up by 4.12% to Rs 143.85, and the company’s market value is Rs 38,623 crore. 

The stock reached its lowest point in 52 weeks at Rs 124.50 on March 20, 2024, but experts see Rs 137 as a strong support level and Rs 145 as resistance. If the stock goes above Rs 145, it could rise to Rs 150 or even Rs 180 soon. 

IREDA is a government-run company under the Ministry of New and Renewable Energy (MNRE). It has been helping promote renewable energy and energy-saving projects for over 36 years. Recently, the company’s borrowing plan for 2024-25 was increased by Rs 5,000 crore to Rs 29,200 crore, which will help fund more projects. This news caused the stock to go up by 4.6%. 

However, IREDA also faced some challenges. The Reserve Bank of India (RBI) did not approve its request to invest in a 900 MW Hydro Electric Power Project in Nepal. Financially, IREDA saw a rise in Non-Performing Assets (NPAs), which went up by 30.4% to Rs 1,845.5 crore, and Net NPAs increased by 53.75%. But the company still reported a 39% increase in Net Interest Income (NII) to Rs 622.25 crore, and its net profit grew by 27% to Rs 425.4 crore. 

Even though the stock has fallen 35% this year, the company’s strong growth in profits and new borrowing plans show that it could recover and perform better in the future. 

IREDA is a government company that supports renewable energy projects in India. It plans to raise ₹29,500 crore this year to fund these projects. Of this amount, ₹25,000 crore will come from loans, and ₹4,500 crore will come from selling company shares. The company is seeking government approval to reduce its ownership by up to 10% to make this possible. 

IREDA also aims to increase its loan portfolio from ₹59,650 crore at the end of last year to over ₹85,000 crore by the end of this year. To maintain its strong financial rating, the company is working to keep a healthy balance between its loans and available capital. 

In September 2024, the Indian government announced plans to sell a 7% stake in IREDA through a share sale. This sale aims to raise up to ₹4,500 crore and will help fund clean energy projects across the country. 

Potentials: 

Looking ahead, IREDA is exploring international expansion opportunities. The company has submitted a draft Green Taxonomy to the Ministry of New & Renewable Energy, which is in an advanced stage. This initiative aims to increase funding for climate-related projects and attract global green investments. 

Overall, IREDA’s plans focus on raising funds, expanding its loan portfolio, maintaining a strong financial position, and supporting India’s renewable energy goals. 

Analyst Insights: 

  • Market capitalisation: ₹ 39,258 Cr. 
  • Current Price: ₹ 146 
  • 52-Week High/Low:₹ 310 / 124 
  • Stock P/E: 25.6 
  • Dividend Yield: 0.00 % 
  • Return on Capital Employed (ROCE): 9.30 % 
  • Return on Equity: 17.3 % 

IREDA has shown strong growth, with profits increasing by about 33.9% per year over the last five years. The company’s earnings and profits are rising, which suggests it’s doing well. Its revenue has also gone up a lot in the past year. But, the stock price is high compared to its earnings, meaning it might be expensive right now. Also, the company doesn’t pay dividends and has some issues with how it handles interest costs. Still, since IREDA is a leader in the green energy field and the government is pushing for more renewable energy, the company has good chances of continuing to grow. This makes it a Hold for now. 

Medico Remedies Ltd
Medico Remedies Ltd Stock Plunges 31% – Is It a Buying Opportunity or a Value Trap?

Business and Industry Overview: 

Medico Remedies Ltd (MRL) is a company that makes and sells medicines. It started in 1994 and mainly makes medicines for bacterial infections. The company also makes antibiotics, painkillers, diabetes medicines, heart medicines, antifungal and antimalarial drugs, anti-ulcer medicines, antacids, and vitamins. It also makes creams, gels, syrups, and other medicines for different health problems. The company has a factory in Palghar, where it produces 122.6 million tablets, 36 million capsules, and 0.12 metric tons of dry syrup every month. It uses good-quality ingredients from trusted suppliers to make safe and effective medicines. Harshit Mehta is the Managing Director of Medico Remedies Ltd. He studied pharmacy at the University of Mumbai and also studied family business management at S P Jain Institute in Mumbai. In the third quarter of 2024-2025, the company’s profit grew by 80.69% compared to the same time last year. 

On May 26, 2022, the company moved from a smaller stock market (BSE SME) to a bigger one (BSE and NSE). In 2021, it gave extra shares to investors in a 3:1 ratio and increased its share capital from ₹4.5 crore to ₹17 crore. In 2023, it split one ₹10 share into five ₹2 shares. In 2022, 93% of the company’s money came from selling its own medicines, 3% from selling other goods, and the rest from labor charges, DEPB license transfers, and other income. The company sells its medicines in many countries, including the Dominican Republic (26%), Honduras (20%), Nigeria (12%), the Philippines (8%), Iraq (6%), Mali (6%), Myanmar (6%), and Kenya (4%). 

India’s pharmaceutical industry was worth $42 billion in 2021 and may grow to $130 billion by 2030. India makes the most generic medicines in the world and supplies 60% of all vaccines. Many countries like the US, UK, Canada, and Europe buy medicines from India. In 2023, India’s domestic market was $41 billion, and exports made $25.3 billion. India has 670 US-approved medicine factories, the most outside the US. Major medicine hubs include Mumbai, Hyderabad, Bangalore, and Ahmedabad. The government helps medicine companies by giving money and tax benefits. In 2020, the PLI Scheme gave $2 billion to help Indian companies make better medicines. India is also making more of its own raw materials to depend less on China. Foreign companies can invest fully in new medicine businesses. India’s biotech industry is also growing fast. It made $1.8 billion in 2009-10 and is expected to grow more. With government support, new investments, and low-cost medicines, India’s pharma industry will keep growing. 

Medico Remedies Ltd is a mid-sized pharmaceutical company in India. It makes generic medicines for pain, allergies, diabetes, and more. The company has a WHO-GMP approved factory, which means it follows high-quality standards. It mainly sells in India but also exports some products. Its market value is smaller than big pharma companies, but it is known for quality and affordable medicines. 

Latest Stock News: 

Medico Remedies Ltd’s stock fell by 19.99% to ₹50.7. It was the biggest loser in the BSE ‘B’ group. More shares were traded than usual. In the last month, the stock dropped 31%, and in the past year, it fell 42%. Even after this drop, the stock’s P/E ratio is 47.5x, which is higher than most Indian companies with a P/E below 25x. The company’s earnings are growing, so some investors expect good performance in the future. But if that doesn’t happen, investors may worry about the stock price. 

Potentials: 

Medico Remedies Ltd wants to grow by making good-quality, affordable medicines. The company plans to make more types of medicines for different health problems. It may increase production to make more medicines. It also wants to sell in more countries, which can help it earn more money. The company follows strict quality rules, so more people may trust its products. But there is a lot of competition, and its stock price goes up and down. If it manages money well and grows carefully, it can become a stronger company in the future. 

Analyst Insights: 

  • Market capitalisation: ₹ 469 Cr. 
  • Current Price: ₹ 56.7 
  • 52-Week High/Low:₹ 90.0 / 34.8 
  • P/E Ratio: 53.0 
  • Dividend Yield:0.00 % 
  • Return on Capital Employed (ROCE): 21.3 % 
  • Return on Equity (ROE): 17.2 % 

Medico Remedies has grown its profits well, but its sales growth is slow. The stock price is high compared to earnings and book value, making it expensive. Even though the company makes profits, it does not pay dividends. Promoters have reduced their stake, which may be a concern. Customers are taking longer to pay, affecting cash flow. There are also signs that the company might be adjusting interest costs to look better. It may be better to wait before investing until the stock price drops or the company shows stronger growth. 

SBI Q3 FY25 Results
SBI Q3 FY25 Results: Strong Net Profit Jumps 83% YoY

State Bank of India Ltd: Overview 

State Bank of India (SBI), established in 1955, is India’s largest public sector bank, with a rich legacy tracing back to the Bank of Calcutta in 1806. Headquartered in Mumbai, SBI operates an extensive network of over 22,405 branches across India and 235 offices in 29 countries, serving more than 45 crore customers. The bank offers a comprehensive range of financial services, including retail and corporate banking, investment banking, asset management, and insurance. SBI’s commitment to technological innovation is evident in its digital platforms like YONO (You Only Need One), which integrates various financial services into a single mobile application, enhancing customer convenience and engagement. The Indian banking industry is experiencing significant transformation, driven by technological advancements, regulatory reforms, and evolving customer expectations. Public sector banks like SBI are pivotal in promoting financial inclusion, especially in rural and semi-urban areas. The sector is witnessing increased competition from private banks and fintech companies, necessitating continuous innovation and customer-centric strategies. Despite challenges such as non-performing assets and economic fluctuations, the outlook for the Indian banking industry remains positive, with opportunities arising from economic growth, infrastructure development, and a burgeoning middle class. 

Latest Stock News 

SBI has maintained its strong position in the domestic banking sector with a sustained market share of over 22%, driven by its extensive reach, customer trust, and value-added services. The bank’s current account balances witnessed a robust growth of 14.22% year-on-year, while total deposits surpassed ₹52 lakh crore, reflecting strong customer confidence. Domestic credit growth stood at 14.06% year-on-year, with significant expansion across various business segments. Whole Bank Advances crossed ₹40 lakh crore, supported by broad-based credit growth exceeding the market average, with the domestic credit-to-deposit ratio at 68.94%. SBI continues to demonstrate industry-leading asset quality, with a credit cost of just 0.24% for the quarter. The stressed book remains well provided for, with a provision coverage ratio (PCR) of 74.66%. Net Non-Performing Assets (NPA) stood at ₹21,378 crore, with additional provisions of ₹29,757 crore that are not included in the PCR, further strengthening the bank’s financial stability. The bank has also made significant strides in digital banking, with over 98% of transactions being conducted through alternate channels. The YONO platform continues to be a key growth driver, accounting for 64% of new savings accounts opened in Q3FY25 and boasting 8.45 crore registered customers. Customer credit has crossed the ₹6 trillion milestones for the first time, with gross advances growing by 10.35% year-on-year. Key international branches, including those in New York, GIFT City, Singapore, DIFC Dubai, and Hong Kong, have significantly contributed to this growth. Additionally, SBI has improved its asset quality, with the gross NPA ratio declining by 9 basis points year-on-year, reflecting its commitment to maintaining financial resilience and sustainable growth. 

Business Segments 

  • Retail Banking: This segment caters to individual customers, offering products like savings and current accounts, personal loans, home loans, and credit cards. SBI’s extensive branch network and digital platforms facilitate widespread access to banking services across urban and rural areas. 
  • Corporate Banking: SBI provides a range of services to corporate clients, including working capital finance, term loans, cash management, and trade finance. The bank supports large, mid-sized, and small enterprises, contributing significantly to industrial and economic development. 
  • Treasury Operations: This segment manages the bank’s investments in government and corporate securities, money market operations, and foreign exchange activities. Effective treasury management enhances SBI’s profitability and liquidity position. 

Subsidiary Information 

  • SBI Capital Markets Limited (SBICAPS): SBI Capital Markets Limited (SBICAPS) is a wholly-owned subsidiary of the State Bank of India, established in 1986, with a primary focus on providing investment banking and corporate advisory services. SBICAPS plays a critical role in advising large corporate, government entities, and financial institutions on mergers and acquisitions, capital raising, and financial restructuring.  
  • SBI DFHI Limited: SBI DFHI Limited is another key subsidiary of the State Bank of India, formed through the merger of Discount & Finance House of India and SBI Gilts Ltd. This entity serves as a primary dealer in the domestic debt market, handling a wide range of financial instruments, including government securities, treasury bills, and money market instruments. SBI DFHI remains a key player in India’s financial markets, supporting the stability and growth of the country’s debt capital market. 
  • SBI Global Factors Limited: SBI Global Factors Limited is a financial services subsidiary of the State Bank of India that specializes in factoring services, offering working capital solutions to businesses through the purchase of receivables. The company plays a crucial role in enabling businesses to improve their cash flow by converting credit sales into instant funds, thus ensuring smooth operational liquidity. 
  • SBI Life Insurance Company Limited: SBI Life Insurance Company Limited is a prominent joint venture between the State Bank of India and BNP Paribas Cardif, focusing on providing a comprehensive range of life insurance products. With a strong distribution network across India, SBI Life has been a key player in the life insurance sector, offering products such as term insurance, endowment plans, pension schemes, and unit-linked insurance plans (ULIPs). 
  • SBI Cards and Payment Services Limited: SBI Cards and Payment Services Limited is a key subsidiary of the State Bank of India, focusing on the issuance of credit cards and providing payment solutions to millions of customers. As one of India’s leading credit card issuers, SBI Cards offers a wide range of credit card products tailored to different consumer segments. With the rapid adoption of digital transactions in India, SBI Cards has seen significant growth in its customer base and transaction volumes. 

Q3 FY25 Earnings 

  • Revenue of ₹124654 crore in Q3 FY25 up by 10.4% YoY from ₹112868 crore in Q3 FY24.  
  • Financing Loss of ₹-17643 crore in this quarter at a margin of -14% compared to -16% in Q3 FY24. 
  • Profit of ₹19484 crore in this quarter compared to a ₹11598 crore profit in Q3 FY24. 

Financial Summary 

Amount in ₹ Cr Q3 FY24 Q3 FY25 FY23 FY24 
Revenue 112868 124654 350848 439189 
Interest  68092 77397 189981 259736 
Expenses 62653 64890 204303 239750 
Financing Profit -17858 -17634 -43439 -60297 
Financing Margin -16% -14% 12% 14% 
Other Income 33103 43200 122534 155386 
Net Profit 11598 19484 57750 69543 
NPM 10.2% 15.6% 16.4% 15.8% 
EPS 12.4 21.2 62.4 75.2